Basic Colcrys Information

• INN (International Nonproprietary Name): Colchicine.
• Brand Names Available In United Kingdom: Marketed as colchicine (generic); international examples include Colcrys, Gloperba, Mitigare and Lodoco.
• ATC Code: M04AC01.
• Forms & Dosages: Tablet 0.6 mg; capsule 0.6 mg; oral solution 0.6 mg/5 mL.
• Manufacturers In United Kingdom: Not specified.
• Registration Status In United Kingdom: Marketed as colchicine (generic) with similar dosage forms available; prescription-only.
• OTC / Rx Classification: Prescription only / Rx.

Initial Instructions, Warnings And Everyday Integration For UK Patients

Colcrys contains colchicine, an active ingredient with a narrow therapeutic index used for gout and familial Mediterranean fever.

Colchicine is prescription-only in the United Kingdom under MHRA/NHS arrangements and should only be taken on a clinician's advice.

Do not take colchicine if you have severe renal or hepatic impairment, or a known hypersensitivity to the drug.

Avoid combining colchicine with strong CYP3A4 or P‑gp inhibitors when renal or hepatic function is significantly reduced because of risk of fatal toxicity.

If you suspect an overdose — severe vomiting, diarrhoea, breathlessness or confusion — call 999 or go to A&E immediately.

Get an NHS prescription from your GP or rheumatology clinic for colcrys or generic colchicine and ask your community pharmacist for advice on side effects and interactions.

If you pay prescription charges in England, check whether you are exempt from the fee; prescriptions are free in Scotland, Wales and Northern Ireland.

Use a repeat prescription service for long‑term prophylaxis and register for electronic prescribing where available at your GP practice.

Keep colchicine in its original packaging at 20–25°C and protect it from moisture.

Avoid excess alcohol during gout flares if it worsens symptoms, and always carry an up‑to‑date list of current medicines to NHS appointments.

Morning Versus Evening Dosing

Which time you take colchicine depends on the indication and your routine.

For gout prophylaxis the common NHS regimen is 0.6 mg once or twice daily, so choose a time you can stick to every day.

Many patients take a once‑daily dose in the morning with breakfast to fit routines, or in the evening if daytime nausea is a problem.

For acute gout the retail guidance for adults supports an initial 1.2 mg at onset followed by 0.6 mg one hour later, not exceeding 1.8 mg in one hour.

For chronic familial Mediterranean fever doses are divided across the day and should be scheduled consistently.

Select a fixed dosing time and set a phone alarm or use repeat prescription reminders to help adherence.

Taking With Or Without Meals (UK Diet Habits)

Many people find that taking colchicine with or after food reduces nausea and makes the tablets easier to tolerate.

A typical UK breakfast or a tea‑time snack are convenient moments to take a 0.6 mg tablet.

Avoid grapefruit juice around dosing because it can inhibit CYP3A4 and increase colchicine levels.

Avoid prolonged heavy alcohol intake during flares as alcohol may worsen gout and gastrointestinal side effects.

When you collect your medicine, ask the pharmacist about tea and coffee habits if you have GI sensitivity and are worried about nausea.

• Dosing Timing Checklist: Pick a regular time, use reminders, take with food if nausea occurs, and keep medicine in original packaging.
• Practical Tip: If you feel unwell after dosing, contact your pharmacist before adjusting the dose.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Do not use colchicine in patients with severe renal impairment or severe hepatic impairment.

Do not use colchicine in anyone with a known hypersensitivity to the drug.

Avoid combinations with strong CYP3A4 or P‑gp inhibitors in patients with renal or hepatic dysfunction because of potentially fatal toxicity.

Use caution in elderly or frail patients and in those with serious gastrointestinal, cardiac or haematological disease.

If you are pregnant or breastfeeding, discuss colchicine with your clinician because use requires specialist advice.

Activities To Limit (Driving, Work Safety)

If you experience dizziness, profound weakness or severe diarrhoea while taking colchicine, do not drive or operate heavy machinery.

Manual workers should avoid duties that require full alertness if vomiting or diarrhoea impair hydration and concentration.

Contact your GP or pharmacist if you have red‑flag symptoms that prevent safe working.

• Red Flags To Stop Activity: Severe diarrhoea, confusion, new muscle weakness, fainting or breathlessness.
• Medication Checklist To Share: All prescription medicines, any antifungals or macrolide antibiotics, and over‑the‑counter remedies.

Dosage & Adjustments

General Regimen (NHS Guidance)

For an acute gout flare adults: 1.2 mg at onset then 0.6 mg one hour later, not exceeding 1.8 mg in one hour.

For gout prophylaxis adults: 0.6 mg once or twice daily, using the lowest effective maintenance dose.

For familial Mediterranean fever adults: 1.2–2.4 mg per day in one or two divided doses depending on response.

Clinicians in the UK typically follow MHRA/NHS guidance and prefer the lowest effective dose to limit side effects.

Special Cases (Elderly, Comorbidities)

In renal impairment dose reduction or avoidance is required; colchicine is contraindicated in dialysis or markedly reduced GFR.

In severe hepatic impairment avoid colchicine or use a reduced dose with specialist monitoring.

Elderly and frail patients should start with a lower dose and be monitored for GI upset, myopathy and cytopaenias.

For children, colchicine is licensed for familial Mediterranean fever from four years old with starting doses of 0.6–1.2 mg/day and careful titration.

User Testimonials

Positive Reports From UK Patients

Many patients report fast relief from acute gout when colchicine is started early in the flare.

People on low‑dose prophylaxis often describe fewer and less severe flares over time.

Pharmacy counselling at high‑street chains such as Boots or LloydsPharmacy is frequently praised for helping patients manage side effects and interactions.

Patients with FMF commonly report a marked reduction in attack frequency when taking long‑term colchicine under specialist follow‑up.

Common Challenges (Patient.info, NHS Forums)

Gastrointestinal side effects — diarrhoea and nausea — are the most commonly reported problems and can limit tolerability.

Confusion over generic names and tablet strengths is frequent; the current common UK tablet strength is 0.6 mg, not the older 1 mg units.

Patients often worry about interactions with antibiotics or antifungals and are advised to check with their pharmacist before starting new medicines.

• Top Patient Tips: Keep medicines in original packaging, show your medication list at every appointment, and report persistent diarrhoea or muscle pain promptly.
• Benefits Vs Problems: Rapid flare relief versus risk of GI side effects and interaction concerns.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Colchicine is prescription-only in the UK and must be obtained via your GP, rheumatologist or hospital clinic.

Large pharmacy chains such as Boots, LloydsPharmacy and Superdrug dispense colchicine and provide counselling at the point of collection.

Many community pharmacies offer electronic repeat prescriptions and home delivery services for repeat prophylaxis.

Online UK pharmacies may supply colchicine with a valid NHS prescription; avoid suppliers overseas selling without a prescription.

In our online pharmacy, colcrys is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Price Comparison (NHS Prescription Charge Vs Private)

In England most patients pay the NHS prescription charge per item unless they are exempt; prescriptions are free in Scotland, Wales and Northern Ireland.

Private prescription prices vary but generic colchicine 0.6 mg tablets are generally inexpensive.

Branded Colcrys is a US brand and is not usually prescribed in the UK where generic colchicine predominates.

• Checklist For Safe Online Purchasing: Ensure the seller is UK‑registered, requires a valid prescription, and provides pharmacist contact details.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is colchicine (INN).

Typical UK presentations are 0.6 mg tablets or capsules and, in some markets, an oral solution 0.6 mg/5 mL.

Excipients vary by manufacturer; check the patient information leaflet for lactose or other allergens before taking the medicine.

Mechanism Basics Explained Simply

Colchicine reduces inflammation by interfering with microtubule formation in white blood cells, lowering inflammatory cell migration into joints.

Colchicine does not lower uric acid and is classified under ATC code M04AC01 as an antigout preparation with no uric acid effect.

Because it does not affect serum urate, urate‑lowering therapy such as allopurinol may be required separately for recurrent gout.

Main Indications

Approved Uses (MHRA Listing)

Approved indications include treatment of acute gout flares, gout prophylaxis, and familial Mediterranean fever.

For FMF paediatric dosing is licensed from around four years of age with careful titration.

Colchicine is prescribed by GPs and specialists within MHRA‑approved indications and is prescription‑only.

Off‑Label Uses In UK Clinics

Off‑label uses occasionally seen include certain cases of inflammatory pericarditis and research use in cardiovascular secondary prevention.

Such uses demand specialist guidance, local formulary checks and informed consent prior to prescribing.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

There are no major direct interactions with tea or coffee in the data, but grapefruit juice should be avoided as it inhibits CYP3A4.

Excess alcohol can worsen gout and may increase gastrointestinal side effects from colchicine.

Discuss alcohol, diet and habitual drinks with your pharmacist if you have active GI sensitivity.

Drug Conflicts (MHRA Yellow Card Reports)

Colchicine toxicity is increased by strong CYP3A4 or P‑gp inhibitors such as some macrolide antibiotics, azole antifungals, certain antivirals and some calcium channel blockers.

The risk is particularly high in patients with renal or hepatic impairment and can be life‑threatening.

Always present a complete medication list to your pharmacist and report suspected adverse reactions via the MHRA Yellow Card scheme.

• High‑Risk Drugs To Discuss With Your Pharmacist: Macrolide antibiotics, azole antifungals, certain antivirals, strong P‑gp inhibitors.
• What To Tell Your Pharmacist: All prescription medicines, herbal remedies and recent antibiotics or antifungals.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

Recent UK and EU literature continued to support low‑dose colchicine for gout prophylaxis and FMF control while highlighting safety concerns.

Trials from 2022 to 2025 explored low‑dose colchicine in cardiovascular secondary prevention with mixed applicability to routine NHS practice.

Safety signal analyses across these studies reinforce avoiding concurrent strong CYP3A4/P‑gp inhibitors and monitoring in renal and hepatic impairment.

Practical Takeaways For Patients

Clinicians favour the lowest effective maintenance dose and careful review of co‑medications before and during treatment.

Early treatment of an acute gout flare improves outcomes and may reduce duration of pain.

Report persistent diarrhoea, new muscle pain or bruising to your prescriber without delay.

• Study Headlines: Continued support for low‑dose prophylaxis; safety monitoring emphasised.
• Patient Actions: Keep medicines list up to date, start treatment early in a flare, and report red‑flag symptoms.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

For acute gout, NSAIDs such as indomethacin or naproxen are frequently used where safe and appropriate.

Oral corticosteroids or intra‑articular steroid injections are options if NSAIDs are contraindicated.

For chronic urate lowering, allopurinol and febuxostat reduce serum urate but do not treat acute inflammation.

• NSAIDs: Rapid anti‑inflammatory effect but carry GI and renal risks.
• Steroids: Potent anti‑inflammatory but systemic effects may limit long‑term use.
• Colchicine: Useful when NSAIDs are contraindicated and for prophylaxis; narrow therapeutic index and interaction risks must be managed.

When Colchicine Is Preferred

Colchicine is often chosen when NSAIDs are contraindicated due to renal disease or peptic ulcer disease.

Long‑term colchicine is the standard prophylactic choice for familial Mediterranean fever under specialist care.

Biologics or anakinra are reserved for refractory or severe cases that do not respond to standard therapy.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

In the UK colchicine is a prescription‑only medicine regulated by the MHRA and prescribed according to local NHS formularies.

Clinicians and pharmacists should check MHRA safety notices and local formulary guidance prior to off‑label prescribing.

Repeat prescriptions are processed by GP practices and community pharmacists may provide adherence support and counselling.

International Context (FDA/EMA Notes)

Colchicine has longstanding approvals internationally, including FDA approval in the United States since 1961 for Colcrys.

The EMA and national regulators licence colchicine generics across Europe with similar dosing forms such as 0.6 mg tablets and oral solution in some markets.

Always consult the appropriate national registry or agency for current product licences in specific countries.

FAQ Section

Common UK Patient Questions

Can I drive while taking colchicine? — If you feel dizzy, weak, or have severe diarrhoea, do not drive; otherwise normal activities are usually safe.

What if I forget a dose? — Take it as soon as you remember unless it is near the time of the next dose; do not double up.

Can I buy colchicine over the counter? — No, colchicine is prescription‑only in the UK and should be obtained via GP or clinic.

Will colchicine affect my other medicines? — It may interact with many drugs, notably strong CYP3A4 and P‑gp inhibitors; bring a full medicines list to your pharmacist.

Emergency Signs Action Checklist: For severe vomiting, diarrhoea, muscle weakness, confusion or difficulty breathing go to A&E or call 999 immediately.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Pharmacists should confirm the tablet strength supplied, typically 0.6 mg in the UK, and explain the dosing schedule clearly.

They should highlight red flags such as severe diarrhoea, myopathy and signs of bone marrow suppression and advise when to stop the medicine and seek help.

Pharmacists will review co‑medications for interactions and advise on storage at 20–25°C, protecting the product from moisture.

Encourage patients to report adverse effects to the MHRA Yellow Card scheme.

NHS Patient Support Advice

Keep an up‑to‑date medicines list and request repeat prescriptions via your GP practice or online services where available.

Book blood tests and clinical review if you are on long‑term colchicine therapy, particularly with renal or hepatic impairment.

For FMF or recurrent gout, seek specialist rheumatology or metabolic clinic support through NHS referral pathways.

• Counselling Checklist: Confirm dose/strength, discuss interactions, and explain emergency signs and monitoring requirements.
• Support Contacts: GP surgery, local pharmacy, NHS 111 for urgent advice, and rheumatology clinic for specialist follow‑up.

Delivery Across United Kingdom

Final Practical Notes

Colchicine tablets are commonly supplied as 0.6 mg units in the UK, so check your packet and dosing instructions carefully.

Always tell your pharmacist about any antibiotic, antifungal or antiviral therapy you are taking before starting colchicine.

Seek urgent help for signs of severe toxicity such as persistent vomiting, diarrhoea, breathlessness, confusion or new muscle weakness.

Use the MHRA Yellow Card scheme to report serious adverse reactions so regulators can monitor safety signals.

When starting urate‑lowering therapy such as allopurinol, colchicine prophylaxis may be advised for a period to reduce flare frequency; discuss this with your prescriber.

Keep your medicine in original packaging at 20–25°C and bring your medication list to every NHS appointment.